210 citations,
November 2015 in “The Lancet HIV” PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.
23 citations,
March 2019 in “AIDS Care” This study explored challenges in accessing and adhering to HIV pre-exposure prophylaxis (PrEP) among participants from a large U.S. urban clinical center and evaluated the effectiveness of urine tenofovir (TFV) monitoring for adherence. It found that 65% of participants began PrEP within 1-3 months of learning about it, though 35% faced providers unwilling to prescribe it. The main barrier to adherence was remembering to take the medication (44%), rather than cost or stigma. Urine TFV monitoring was well-received, with participants preferring it every 3 months over other methods like finger prick or hair follicle testing. The study underscored the need to reduce obstacles to PrEP use and supported urine TFV monitoring as a reliable adherence measure.
August 2012 in “Journal of Evidence-Based Medicine” The issue discussed China's research contributions, systematic review improvements, and featured various medical studies and trials.
47 citations,
February 2019 in “Journal of The American Academy of Dermatology” LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.
November 2023 in “Australasian journal of dermatology” Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.